Jaime Zwiebel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 MARIO-3 Phase 2 study evaluating eganelisib added to standard of care Tecentriq® and Abraxane® regimen in frontline triple negative breast cancer (TNBC)Investor Event with KOL Scheduled for Friday, December 10th @ 9:30am ETCAMBRIDGE, Mass. (BUSINESS WIRE) Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-. ....

United States , United Kingdom , Irina Koffler , Jaime Zwiebel , Howard Streicher , Hatem Soliman , Daniel Sullivan , Robert Ilaria , Lifesci Advisors , Baxter Healthcare Corporation , College Of Georgia , University Of Georgia Athens , Genentech Inc , Moffitt Cancer Center , University Of South Florida Moffitt Cancer Center , Abraxis Bioscience , Bristol Myers Squibb Company , Bristol Myers Squibb , Infinity Pharmaceuticals Inc , Clinical Trials Office , Infinity Pharmaceuticals , San Antonio Breast Cancer Symposium , Key Opinion Leader , Medical Director , Moffitt Cancer , Chief Medical Officer ,